Laura Heathcote

Mar 12, 2024 | drc.bmj.com | Laura Heathcote |Daniel Pollard |Alan Brennan |Melanie J. Davies

WHAT IS ALREADY KNOWN ON THIS TOPICHOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE, OR POLICYIntroductionIt is estimated that diabetes affects just under half a billion people worldwide, of whom approximately 90% in high-income countries have type 2 diabetes (T2D).1 People with T2D have an elevated risk of developing serious complications such as renal failure, blindness, amputation, cardiovascular disease (CVD), depression, and osteoarthritis.

Mar 1, 2024 | drc.bmj.com | Laura Heathcote |Daniel Pollard |Alan Brennan |Melanie J. Davies

MethodsThis analysis was a lifetime horizon, model-based cost-utility analysis using the School for Public Health Research (SPHR) Diabetes Prevention Model v3.2 (hereafter referred to as “the model”),19 20 as prespecified in the PROPELS health economics analysis plan. A model-based analysis was conducted for two reasons.

Nov 22, 2022 | dovepress.com | Laura Heathcote

Jun 9, 2015 | nzherald.co.nz | Laura Heathcote

Jun 9, 2015 | nzherald.co.nz | Laura Heathcote